China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

Hepatobiliary cancers, which include biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), are among the most lethal ...

门静脉癌栓（portal vein tumor thrombus，PVTT）是肝细胞癌（hepatocellular carcinoma，HCC）最常见的血管侵犯形式。HCC 患者合并 PVTT 的发生率为 ...

Results of CHANCE 2005/CARES-005 study were unveiled by Dr Gao-Jun Teng from Zhongda Hospital, Southeast University, China, ...

Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...

1. 百时美施贵宝宣布，欧洲药品管理局人用药品委员会推荐批准其PD-1抑制剂Opdivo与CTLA-4靶向抗体Yervoy联合疗法用于不可切除或晚期肝细胞癌成人患者的一线治疗。 2. 3期CheckMate-9DW临床试验结果显示，Opdivo联合Yervoy治疗在临床与统计学上显著延长主要终点OS，中位OS为23.7个月，而活性对照药物治疗患者的中位OS为20.6个月。

Hundreds of a people who have chronic liver disease are being helped by an NHS trust's service that helps them attend vital ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma.

The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...

During the conference, Can-Fite's management team will engage in one-on-one meetings with investors and potential partners to discuss the company’s business strategy, recent clinical milestones, and ...